The ELISA results showed that serum anti-CXCL8 autoantibody expression level was notably higher in ESCC patients than in normal controls in both the verification set and validation set (p < 0.05) (Figure 4A,C). Here, CXCL8 is linked to esophageal squamous cell carcinoma.